Human colon carcinomas constitutively express and shed type II IL-1 receptor, an IL-1 antagonist

Andrew W Stadnyk1, Moorix M W Yeung, Sen Rong Yan

  • 1Department of Pediatrics, Dalhousie Inflammation Group, Dalhousie University, Halifax, Nova Scotia, Canada.

Insights

Human colon cells express the IL-1 receptor type II (IL-1RII), an IL-1 antagonist. This finding suggests IL-1RII plays a role in regulating inflammation in the human gut.

Area of Science:

  • Immunology
  • Gastroenterology
  • Cell Biology

Background:

  • Rat intestinal cells express IL-1RII in response to helminth infection, NSAID injury, and detachment.
  • The role of IL-1RII in human intestinal epithelial cells remains largely unexplored.

Purpose of the Study:

  • To determine if human colon carcinoma cell lines express IL-1RII.
  • To investigate if IL-1RII expression can be induced in these cells.
  • To assess the functional significance of IL-1RII in human intestinal epithelial cells.

Main Methods:

  • Reverse transcription-polymerase chain reaction (RT-PCR) to detect IL-1RII mRNA.
  • Immunohistochemistry to detect IL-1RII protein.
  • Western blotting to estimate protein size.
  • Tumor Necrosis Factor (TNF) treatment to assess induction of IL-1RII.
  • Treatment with inhibitory anti-IL-1RII antibodies to measure IL-8 production.

Main Results:

  • T84 and HT-29 cell lines constitutively expressed mRNA for the membrane-bound IL-1RII.
  • TNF treatment increased IL-1RII mRNA and soluble protein levels in T84 cells.
  • Blocking IL-1RII function enhanced IL-1-induced IL-8 production in T84 cells.

Conclusions:

  • Human colon carcinoma cell lines express the membrane-bound IL-1RII.
  • IL-1RII expression can be modulated by TNF treatment.
  • IL-1RII acts as an antagonist to IL-1, influencing IL-8 production in human intestinal epithelial cells, with implications for inflammatory gut diseases.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the goblet,...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...